相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitors of dihydrofolate reductase as antitumor agents: design, synthesis and biological evaluation of a series of novel nonclassical 6-substituted pyrido[3,2-d]pyrimidines with a three-to five-carbon bridge
Hao Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents
Chao Tian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for antiproliferative activity
Hu-Li Ng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis
Yi Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Nonclassical antifolates, part 5. Benzodiazepine analogs as a new class of DHFR inhibitors: Synthesis, antitumor testing and molecular modeling study
Hussein I. El-Subbagh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Immunosuppressive Drug Azathioprine Reduces Aneurysm Progression Through Inhibition of Rac1 and c-Jun-Terminal-N-Kinase in Endothelial Cells
Goran Marinkovic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Nonclassical antifolates, part 3: Synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones
Fatmah A. M. Al-Omary et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Lysosomes and lysosomal cathepsins in cell death
Urska Repnik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Nitzan Gonen et al.
DRUG RESISTANCE UPDATES (2012)
Synthesis and Biological Activity of 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Inhibitors of de Novo Purine Biosynthesis with Selectivity for Cellular Uptake by High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier
Lei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
2,4-Diamino-5-(2′-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition
Oztekin Algul et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
Folate, DNA damage and the aging brain
Michael Fenech
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Lysosomal and mitochondrial pathways in miltefosine-induced apoptosis in U937 cells
Caroline Paris et al.
APOPTOSIS (2007)
Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents:: Design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates
A Gangjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Synthesis of classical, four-carbon bridged 5-substituted furo [2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates
A Gangjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis
MJ Boeree et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2005)
Lysosomes in cell death
ME Guicciardi et al.
ONCOGENE (2004)
Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier
RB Zhao et al.
CLINICAL CANCER RESEARCH (2004)
Functional analysis of altered reduced folate carrier sequence changes identified in osteosarcomas
WF Flintoff et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Anticancer antifolates: Current status and future directions.
JJ McGuire
CURRENT PHARMACEUTICAL DESIGN (2003)
Deaza analogs of folic acid as antitumor agents
RL Kisliuk
CURRENT PHARMACEUTICAL DESIGN (2003)
分享论文
